Wells Fargo & Company Eton Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.48 - $5.03 $4,360 - $6,302	1,253 Added 728.49%	1,425 $5,000
Q4 2023 Feb 09, 2024	BUY	$3.45 - $4.66 $31 - $41	9 Added 5.52%	172 $0
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.63 $28 - $61	11 Added 7.24%	163 $0
Q2 2023 Aug 15, 2023	BUY	$3.32 - $4.04 $23 - $28	7 Added 4.83%	152 $0
Q1 2023 May 12, 2023	SELL	$2.89 - $4.1 $11,554 - $16,391	-3,998 Reduced 96.5%	145 $0
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $8 - $13	4 Added 0.1%	4,143 $11,000
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.03 $2 - $3	1 Added 0.02%	4,139 $9,000
Q2 2022 Aug 12, 2022	SELL	$2.55 - $4.38 $8,889 - $15,268	-3,486 Reduced 45.72%	4,138 $11,000
Q1 2022 May 16, 2022	BUY	$3.43 - $4.69 $25,725 - $35,175	7,500 Added 6048.39%	7,624 $34,000
Q4 2021 Feb 14, 2022	BUY	$3.66 - $6.59 $3 - $6	1 Added 0.81%	124 $1,000
Q3 2021 Nov 15, 2021	SELL	$4.2 - $6.26 $1,327 - $1,978	-316 Reduced 71.98%	123 $1,000
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $90,857 - $140,821	-15,912 Reduced 97.32%	439 $3,000
Q1 2021 May 13, 2021	SELL	$6.93 - $10.07 $67,345 - $97,860	-9,718 Reduced 37.28%	16,351 $120,000
Q4 2020 Feb 09, 2021	BUY	$6.65 - $8.83 $36,894 - $48,988	5,548 Added 27.04%	26,069 $212,000
Q3 2020 Nov 05, 2020	SELL	$4.96 - $9.06 $42,616 - $77,843	-8,592 Reduced 29.51%	20,521 $162,000
Q2 2020 Aug 13, 2020	BUY	$3.5 - $6.09 $91,140 - $158,583	26,040 Added 847.38%	29,113 $158,000
Q1 2020 May 14, 2020	BUY	$2.87 - $7.47 $8,819 - $22,955	3,073 New	3,073 $12,000

8.16M

41K

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $174M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.